Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Iida Vähätalo, Hannu Kankaanranta, Leena E Tuomisto, Onni Niemelä, Lauri Lehtimäki, Pinja Ilmarinen, Iida Vähätalo, Hannu Kankaanranta, Leena E Tuomisto, Onni Niemelä, Lauri Lehtimäki, Pinja Ilmarinen
Abstract
Background: In short-term studies, poor adherence to inhaled corticosteroids (ICS) has been associated with worse asthma control, but the association of long-term adherence and disease control remains unclear.
Objective: To assess the relationship between 12-year adherence to ICS and asthma control in patients with adult-onset asthma.
Methods: As part of the Seinäjoki Adult Asthma Study, 181 patients with clinically confirmed new-onset adult asthma and regular ICS medication were followed-up for 12 years. Adherence (%) to ICS was assessed individually ((µg dispensed/µg prescribed)×100) during the follow-up. Asthma control was evaluated after 12 years of treatment according to the Global Initiative for Asthma 2010 guideline.
Results: Asthma was controlled in 31% and not controlled (partly controlled or uncontrolled) in 69% of the patients. Patients with not-controlled asthma were more often male, older, nonatopic and used higher doses of ICS than those with controlled disease. The mean±sd 12-year adherence to ICS was 63±38% in patients with controlled asthma and 76±40% in patients with not-controlled disease (p=0.042). Among patients with not-controlled asthma, those with lower 12-year adherence (<80%) had more rapid decline in forced expiratory volume in 1 s (-47 mL·year-1) compared to patients with better adherence (≥80%) (-40 mL·year-1) (p=0.024). In contrast, this relationship was not seen in patients with controlled asthma.
Conclusions: In adult-onset asthma, patients with not-controlled disease showed better 12-year adherence to ICS treatment than those with controlled asthma. In not-controlled disease, adherence <80% was associated with more rapid lung function decline, underscoring the importance of early recognition of such patients in routine clinical practice.
Conflict of interest statement
Conflict of interest: I. Vähätalo has nothing to disclose. Conflict of interest: H. Kankaanranta reports fees for lectures and consulting, costs for attending an international congress, and research grant to his institution from AstraZeneca; fees for consulting from Chiesi Pharma AB; fees for lectures and consulting, and costs for attending an international congress from Boehringer Ingelheim; fees for lectures and consulting from Novartis; fees for lectures from Mundipharma; fees for lectures and consulting, and costs for attending international congress from Orion Pharma; fees for consulting from SanofiGenzyme; and fees for lectures and consulting from GlaxoSmithKline, all outside the submitted work. Conflict of interest: L.E. Tuomisto reports costs for attending an international congress and costs for lecture from Boehringer Ingelheim, and costs for a lecture from AstraZeneca, outside the submitted work. Conflict of interest: O. Niemelä has nothing to disclose. Conflict of interest: L. Lehtimäki reports personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Circassia, GSK, Novartis, Mundipharma, Orion Pharma, Sanofi and Teva, outside the submitted work. Conflict of interest: P. Ilmarinen reports a grant for analysis and write-up of a study, and a fee for a lecture from AstraZeneca; fees for lectures from Mundipharma and GlaxoSmithKline; and a fee for a lecture and for preparing presentation material from Novartis, all outside the submitted work.
Copyright ©ERS 2021.
Figures
References
- Engelkes M, Janssens HM, de Jongste JC, et al. . Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J 2015; 45: 396–407. doi:10.1183/09031936.00075614
- Gold LS, Smith N, Allen-Ramey FC, et al. . Associations of patient outcomes with level of asthma control. Ann Allergy Asthma Immunol 2012; 109: 260–265. doi:10.1016/j.anai.2012.07.024
- Tuomisto LE, Ilmarinen P, Niemelä O, et al. . A 12-year prognosis of adult-onset asthma: Seinäjoki Adult Asthma Study. Respir Med 2016; 117: 223–229. doi:10.1016/j.rmed.2016.06.017
- Braido F, Brusselle G, Guastalla D, et al. . Determinants and impact of suboptimal asthma control in Europe: The International Cross-Sectional and Longitudinal Assessment on Asthma Control (LIAISON) study. Respir Res 2016; 17: 51. doi:10.1186/s12931-016-0374-z
- Global Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention 2020. Available from:
- Ilmarinen P, Tuomisto LE, Kankaanranta H. Phenotypes, risk factors and mechanisms of adult-onset asthma. Mediators Inflamm 2015; 2015: 514868. doi:10.1155/2015/514868
- Wenzel SE Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18: 716–725. doi:10.1038/nm.2678
- Vähätalo I, Ilmarinen P, Tuomisto LE, et al. . 12-year adherence to inhaled corticosteroids in adult-onset asthma. ERJ Open Res 2020; 6: 00324-2019. doi:10.1183/23120541.00324-2019
- Krishnan JA, Bender BG, Wamboldt FS, et al. . Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial. J Allergy Clin Immunol 2012; 129: 112–118. doi:10.1016/j.jaci.2011.10.030
- Kosse RC, Koster ES, Kaptein AA, et al. . Asthma control and quality of life in adolescents: the role of illness perceptions, medication beliefs, and adherence. J Asthma 2020; 57: 1145–1154. doi:10.1080/02770903.2019.1635153
- Allegra L, Cremonesi G, Girbino G, et al. . Real-life prospective study on asthma control in Italy: cross-sectional phase results. Respir Med 2012; 106: 205–214. doi:10.1016/j.rmed.2011.10.001
- Clatworthy J, Price D, Ryan D, et al. . The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009; 18: 300–305. doi:10.4104/pcrj.2009.00037
- Dima AL, van Ganse E, Stadler G, et al. . Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study. Eur Respir J 2019; 54: 1900901. doi:10.1183/13993003.00901-2019
- Price D, Harrow B, Small M, et al. . Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J 2015; 8: 26. doi:10.1186/s40413-015-0075-y
- Roche N, Plaza V, Backer V, et al. . Asthma control and COPD symptom burden in patients using fixed-dose combination inhalers (SPRINT study). NPJ Prim Care Respir Med 2020; 30: 1. doi:10.1038/s41533-019-0159-1
- Smits D, Brigis G, Pavare J, et al. . Factors related to good asthma control using different medical adherence scales in Latvian asthma patients: an observational study. NPJ Prim Care Respir Med 2017; 27: 39. doi:10.1038/s41533-017-0042-x
- Munoz-Cano R, Torrego A, Bartra J, et al. . Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study). Eur Respir J 2017; 49: 1501885. doi:10.1183/13993003.01885-2015
- Chiu KC, Boonsawat W, Cho SH, et al. . Patients’ beliefs and behaviors related to treatment adherence in patients with asthma requiring maintenance treatment in Asia. J Asthma 2014; 51: 652–659. doi:10.3109/02770903.2014.898772
- Ilmarinen P, Tuomisto LE, Niemelä O, et al. . Prevalence of patients eligible for anti-IL-5 treatment in a cohort of adult-onset asthma. J Allergy Clin Immunol Pract 2019; 7: 165–174. doi:10.1016/j.jaip.2018.05.032
- Klok T, Kaptein AA, Duiverman EJ, et al. . It's the adherence, stupid (that determines asthma control in preschool children)!. Eur Respir J 2014; 43: 783–791. doi:10.1183/09031936.00054613
- Papi A, Ryan D, Soriano JB, et al. . Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate-to-severe asthma. J Allergy Clin Immunol Pract 2018; 6: 1989–1998. doi:10.1016/j.jaip.2018.03.008
- Kandane-Rathnayake RK, Matheson MC, Simpson JA, et al. . Adherence to asthma management guidelines by middle-aged adults with current asthma. Thorax 2009; 64: 1025–1031. doi:10.1136/thx.2009.118430
- Murphy AC, Proeschal A, Brightling CE, et al. . The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax 2012; 67: 751–753. doi:10.1136/thoraxjnl-2011-201096
- Vähätalo I, Ilmarinen P, Tuomisto LE, et al. . Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study. Respir Med 2018; 137: 70–76. doi:10.1016/j.rmed.2018.02.025
- Kankaanranta H, Ilmarinen P, Kankaanranta T, et al. . Seinäjoki Adult Asthma Study (SAAS): a protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care. NPJ Prim Care Respir Med 2015; 25: 15042. doi:10.1038/npjpcrm.2015.42
- Haahtela T, Klaukka T, Koskela K, et al. . Asthma programme in Finland: a community problem needs community solutions. Thorax 2001; 56: 806–814. doi:10.1136/thorax.56.10.806
- Global Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention 2010. Available from:
- Bijlsma MJ, Janssen F, Hak E. Estimating time-varying drug adherence using electronic records: extending the proportion of days covered (PDC) method. Pharmacoepidemiol Drug Saf 2016; 25: 325–332. doi:10.1002/pds.3935
- van Boven JFM, Koponen M, Lalic S, et al. . Trajectory analyses of adherence patterns in a real-life moderate to severe asthma population. J Allergy Clin Immunol Pract 2020; 8: 1961–1969. doi:10.1016/j.jaip.2019.12.002
- Tommola M, Ilmarinen P, Tuomisto LE, et al. . The effect of smoking on lung function: a clinical study of adult-onset asthma. Eur Respir J 2016; 48: 1298–1306. doi:10.1183/13993003.00850-2016
- Dreborg S, Frew AJ. Position paper: allergen standardization and skin tests. Allergy 1993; 48: 49–54. doi:10.1111/j.1398-9995.1993.tb04756.x
- Chaudhuri R, McSharry C, McCoard A, et al. . Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy 2008; 63: 132–135. doi:10.1111/j.1398-9995.2007.01538.x
- Ilmarinen P, Tuomisto LE, Niemelä O, et al. . Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma. Eur Respir J 2016; 48: 1052–1062. doi:10.1183/13993003.02198-2015
- Ilmarinen P, Tuomisto LE, Niemelä O, et al. . Cluster analysis on longitudinal data of patients with adult-onset asthma. J Allergy Clin Immunol Pract 2017; 5: 967–978. doi:10.1016/j.jaip.2017.01.027
- Lefaudeux D, De Meulder B, Loza MJ, et al. . U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics. J Allergy Clin Immunol 2017; 139: 1797–1807. doi:10.1016/j.jaci.2016.08.048
- Lazarus SC, Chinchilli VM, Rollings NJ, et al. . Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007; 175: 783–790. doi:10.1164/rccm.200511-1746OC
- Tomlinson JE, McMahon AD, Chaudhuri R, et al. . Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005; 60: 282–287. doi:10.1136/thx.2004.033688
- Sulaiman I, Greene G, MacHale E, et al. . A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma. Eur Respir J 2018; 51: 1701126. doi:10.1183/13993003.01126-2017
Source: PubMed